Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (2 active)

Company-led only

1 result

Therapy	Approach	Progress	Population	Additional Info
PEDMARK by Fennec PharmaceuticalsFennec Pharmaceuticals Compare	Small Molecule	Stage: MarketedStatus: Marketed	Children · ≥1 month (pediatric indication)Localized, non-metastatic tumors receiving cisplatin

Fennec Pharmaceuticals · Small Molecule · Marketed

MarketedTherapeuticStronger sources

Population

Children · ≥1 month (pediatric indication)

Localized, non-metastatic tumors receiving cisplatin

Evidence

regulatory

Confidence

98%

Indications

Cisplatin-Induced Hearing LossHearing Loss

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.